Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Shapiro

Showing results (51-60 of 414) with videos related to

Pageof 42
Sort By:
American Journal of Preventive Cardiology|December 9, 2025
Risk matters for atherosclerotic cardiovascular disease: But vascular resilience may decideMichael D Shapiro, Khurram Nasir
Journal of Diabetes|July 3, 2018
Medication-based versus target-based lipid managementSergio Fazio, Michael D Shapiro
Nature Reviews. Cardiology|May 5, 2017
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL loweringMichael D Shapiro, Sergio Fazio
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 8, 2016
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDSYehuda Handelsman, Michael D Shapiro
European Journal of Preventive Cardiology|September 11, 2018
Biologic bases of residual risk of cardiovascular events: A flawed conceptMichael D Shapiro, Sergio Fazio
European Journal of Preventive Cardiology|July 30, 2025
Preventing Atherosclerosis in the 20's: Rethinking the Starting LineMichael D Shapiro, Eugene Yang
American Journal of Preventive Cardiology|June 15, 2026
Silencing the noise: APOC3 inhibition and the long-overdue reckoning with triglyceridesMichael D Shapiro, Khuram Nasir
Frontiers in Cardiovascular Medicine|March 22, 2019
Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes TrialsNathan D Wong, Michael D Shapiro
Circulation|December 29, 2025
When the Target Is Not the Driver: Rethinking LDL in Cardiac Allograft VasculopathyLauren K Truby, Michael D Shapiro
Developmental Biology|November 17, 2016
Pigeonetics takes flight: Evolution, development, and genetics of intraspecific variationEric T Domyan, Michael D Shapiro
Pageof 42

Showing results (51-60 of 414) with videos related to

Sort By:
Pageof 42
American Journal of Preventive Cardiology|December 9, 2025
Risk matters for atherosclerotic cardiovascular disease: But vascular resilience may decideMichael D Shapiro, Khurram Nasir
Journal of Diabetes|July 3, 2018
Medication-based versus target-based lipid managementSergio Fazio, Michael D Shapiro
Nature Reviews. Cardiology|May 5, 2017
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL loweringMichael D Shapiro, Sergio Fazio
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 8, 2016
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDSYehuda Handelsman, Michael D Shapiro
European Journal of Preventive Cardiology|September 11, 2018
Biologic bases of residual risk of cardiovascular events: A flawed conceptMichael D Shapiro, Sergio Fazio
European Journal of Preventive Cardiology|July 30, 2025
Preventing Atherosclerosis in the 20's: Rethinking the Starting LineMichael D Shapiro, Eugene Yang
American Journal of Preventive Cardiology|June 15, 2026
Silencing the noise: APOC3 inhibition and the long-overdue reckoning with triglyceridesMichael D Shapiro, Khuram Nasir
Frontiers in Cardiovascular Medicine|March 22, 2019
Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes TrialsNathan D Wong, Michael D Shapiro
Circulation|December 29, 2025
When the Target Is Not the Driver: Rethinking LDL in Cardiac Allograft VasculopathyLauren K Truby, Michael D Shapiro
Developmental Biology|November 17, 2016
Pigeonetics takes flight: Evolution, development, and genetics of intraspecific variationEric T Domyan, Michael D Shapiro
Pageof 42